Evidence map›Paper›PMID 38260545›Full record

ArticlebioRxiv : the preprint server for biology2024

Comprehensive and accurate genome analysis at scale using DRAGEN accelerated algorithms.

Sairam Behera, Severine Catreux, Massimiliano Rossi, Sean Truong, Zhuoyi Huang, Michael Ruehle, Arun Visvanath, Gavin Parnaby, Cooper Roddey, Vitor Onuchic and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A splice donor variant inFrontiers in veterinary science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sairam BeheraHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-9047-0203
Severine CatreuxIllumina Inc., San Diego, CA, USA.
Massimiliano RossiIllumina Inc., San Diego, CA, USA.ORCID 0000-0002-3012-1394
Sean TruongIllumina Inc., San Diego, CA, USA.
Zhuoyi HuangIllumina Inc., San Diego, CA, USA.
Michael RuehleIllumina Inc., San Diego, CA, USA.
Arun VisvanathIllumina Inc., San Diego, CA, USA.
Gavin ParnabyIllumina Inc., San Diego, CA, USA.
Cooper RoddeyIllumina Inc., San Diego, CA, USA.
Vitor OnuchicIllumina Inc., San Diego, CA, USA.
Daniel L CameronIllumina Inc., San Diego, CA, USA.ORCID 0000-0002-0951-7116
Adam EnglishHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0003-2451-4375
Shyamal MehtaliaIllumina Inc., San Diego, CA, USA.
James HanIllumina Inc., San Diego, CA, USA.ORCID 0009-0002-0333-7568
Rami MehioIllumina Inc., San Diego, CA, USA.
Fritz J SedlazeckHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-6040-2691

Funding

Frequency of variants of unknown significance by ancestry groups in the All of Us Research Program cohortU01HG011758 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI RICHARD A GIBBS, JAMES R. LUPSKI · 2021 to 2026
$13.8M
NHGRI NIH HHS U01 HG011758
6 · The paper itself

Abstract

Research and medical genomics require comprehensive and scalable solutions to drive the discovery of novel disease targets, evolutionary drivers, and genetic markers with clinical significance. This necessitates a framework to identify all types of variants independent of their size (e.g., SNV/SV) or location (e.g., repeats). Here we present DRAGEN that utilizes novel methods based on multigenomes, hardware acceleration, and machine learning based variant detection to provide novel insights into individual genomes with ~30min computation time (from raw reads to variant detection). DRAGEN outperforms all other state-of-the-art methods in speed and accuracy across all variant types (SNV, indel, STR, SV, CNV) and further incorporates specialized methods to obtain key insights in medically relevant genes (e.g., HLA, SMN, GBA). We showcase DRAGEN across 3,202 genomes and demonstrate its scalability, accuracy, and innovations to further advance the integration of comprehensive genomics for research and medical applications.

Identifiers

PMID38260545
PMCPMC10802302

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.